First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
2024 · Med · 14 citations
https://doi.org/10.1016/j.medj.2024.09.002
Y
Yan Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
197
Citations
8
h-index
6
i10-index
Yan Yu is an academic researcher from Shenzhen University. The author has contributed to research in topics: CAR-T cell therapy research & Lung Cancer Treatments and Mutations & Acute Lymphoblastic Leukemia research. The author has an h-index of 8, co-authored 43 publications.
ORCID: 0009-0001-1551-3445Papers by this author
worksDirect Printing of Disperse Dye Inks to Polyester Fabrics without Chemical Pretreatment
2024 · Langmuir · 6 citations
https://doi.org/10.1021/acs.langmuir.4c01586
A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)
2025 · Journal of Hematology & Oncology · 6 citations
https://doi.org/10.1186/s13045-024-01656-0
Prognostic study of intracranial branch atheromatous disease in the blood-supplying areas of the lenticulostriate and paramedian pontine arteries
2024 · Journal of Stroke and Cerebrovascular Diseases · 4 citations
https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108210
Synthesis and multi-stimuli-responsive fluorescent properties of tetraphenylethylene-armed star-shaped isomer dyes with distinct core structures
2025 · Dyes and Pigments · 0 citations
https://doi.org/10.1016/j.dyepig.2025.113257
KHg <sub>4</sub> Ga <sub>5</sub> S <sub>12</sub> : A Diamond-like Tetrahedral Chalcogenide Exhibiting Giant Phase-Matching Second Harmonic Generation
2026 · Chemistry of Materials · 0 citations
https://doi.org/10.1021/acs.chemmater.5c03230
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat